With the emergence of the new B.1.1.7 (UK) and B.1.351 (Sout...
Read More Necessity of Sequencing Emerging SARS-CoV-2 Variants from UK and S. Africa
With the emergence of the new B.1.1.7 (UK) and B.1.351 (Sout... by Behind The Bench Staff / 01.19.2021
Read More Necessity of Sequencing Emerging SARS-CoV-2 Variants from UK and S. AfricaWhile molecular methods like quantitative polymerase chain r... by Behind The Bench Staff / 01.14.2021
Read More Podcast: Benefits of Targeted NGS for SARS-CoV-2 Epidemiology and Lessons LearnedWritten by Nora Marbaniang, Raghul Mathivanan & Amir Kha... by Behind The Bench Staff / 01.06.2021
Read More Enabling GPCR Research with GPCR AntibodiesThe recent news that a highly transmissible SARS-CoV-2 strai... by Behind The Bench Staff / 12.31.2020
Read More Solutions for surveillance of the S gene mutation in the B.1.1.7 (501Y.V1) SARS-CoV-2 strain lineageUpdated December 30, 2020: While the B.1.1.7 variant has be... by Behind The Bench Staff / 12.24.2020
Read More Thermo Fisher’s COVID-19 tests: designed with virus mutations in mindEmerging biomarkers of immune responses to SARS-CoV-2 infect... by Behind The Bench Staff / 12.10.2020
Read More Targeted NGS Reveals Two Distinct Immune Responses to SARS-CoV-2 Infection from Postmortem Lung Tissue